@IDPharmacometrx @DrToddLee @khalideljaaly @draghafur @jpogue1 @nbritt_pharmd @JGPharmD @FungalDoc @mmPharmD @IDstewardship Ancillary to Saphhire study: https://t.co/RnBNLs8nks looked at vanc and pip/tazo, however it doesn’t say how many patients had seps…
@garyDpeksa @JochenReiser @TWhittier_RUSH TIMP2*IGFBP7 increased before elevations of SCr specific to nephrotoxins https://t.co/8fvzzLnMOc -same for KIM-1 https://t.co/u9iOQnMkpT the former is available for clinical use the latter not. decent data ar…
@IDPharmacometrx As well as the data from Dr. Ostermann re: Nephrocheck 2/ https://t.co/4bsuq92tIv https://t.co/H1KafCtqtU
RT @gorgamd: Basu: It's not just the threshold or the peak, it's the change over time and what's going on in the patient. Kinetics of bioma…